Welcome to the third open thread on the Effective Altruism Forum. This is our place to discuss relevant topics that have not appeared in recent posts. Thanks to an upgrade by Trike Apps, each time you visit the open thread, new comments will now be highlighted!
We certainly talk about this a lot at FHI and do a fair amount of research and policy work on it. CSER is also interested in synthetic biology risk. I agree that it is talked about a lot less in wider EA circles though.